We’re better off with mRNA vaccines

Screenshot 2021-03-16 183548

The technology that is helping us combat COVID-19 is also poised to help us tackle tough infectious and non-infectious diseases. Immunologist Sarah Fortune explains how these vaccines work, and how the mRNA platform could transform the prevention and treatment of deadly diseases.

In this episode of “Better Off,” Harvard Chan School immunologist Sarah Fortune takes on common misconceptions about COVID-19 vaccines, and discusses the ways that mRNA technology could be used to create vaccines for diseases like TB and cancer.